Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 22, 2015 07:03 ET | Source: T3D Therapeutics, Inc.

T3D Therapeutics, Inc. Receives FDA IND Approval to Begin Phase 2 Clinical Study of T3D-959 in Alzheimer's Patients

RESEARCH TRIANGLE PARK, N.C., June 22, 2015 (GLOBE NEWSWIRE) -- via PRWEB - T3D Therapeutics, Inc., a Research Triangle Park, NC-based developer of Alzheimer's disease therapies, announced today that...
March 24, 2015 07:03 ET | Source: T3D Therapeutics, Inc.

T3D Therapeutics, Inc. Awarded SBIR Phase 2 Grant From The National Institute On Aging For Alzheimer's Disease Drug Testing

RESEARCH TRIANGLE PARK, N.C., March 24, 2015 (GLOBE NEWSWIRE) -- via PRWEB - T3D Therapeutics, Inc., a Research Triangle Park, NC-based developer of Alzheimer's disease therapies announced today that...